MoneyWorks4Me

Everest Organics informs about disclosure on related party transactions

28 Nov 2019 Evaluate

In compliance with Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Everest Organics has informed about submission of the applicable disclosure on related party transactions for the half year ended September 30, 2019 in the requisite format. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..